A Safety and Efficacy Study of Tralokinumab in Adults With Asthma
Public ClinicalTrials.gov record NCT01402986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Uncontrolled, Severe Asthma
Study identification
- NCT ID
- NCT01402986
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 689 participants
Conditions and interventions
Conditions
Interventions
- Placebo Q2W Other
- Tralokinumab 300 mg, Q2W Biological
- Placebo, Q2/4W Other
- Tralokinumab 300 mg, Q2/4W Biological
Other · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- May 31, 2013
- Completion
- Jan 31, 2014
- Last update posted
- Apr 3, 2017
2011 – 2014
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Rancho Mirage | California | — | — |
| Research Site | Centennial | Colorado | — | — |
| Research Site | New Haven | Connecticut | — | — |
| Research Site | Cocoa | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Winter Park | Florida | — | — |
| Research Site | Albany | Georgia | — | — |
| Research Site | Fargo | North Dakota | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Upland | Pennsylvania | — | — |
| Research Site | Killeen | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01402986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2017 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01402986 live on ClinicalTrials.gov.